Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

Table 1

Patients’ characteristics and comorbid conditions. NAFLD: nonalcoholic fatty liver disease; BMI: Body Mass Index; SEM: Standard Error of Means.

	Non-hepatic steatosis; n=41	NAFLD; n = 68	p value
Gender	21:20	37:31
(Male: Female)
Age, years
Mean ±SEM	50.4±2.3	53.1±1.5	0.231
BMI, kg/m^2
Mean ± SEM	24.6±0.89	29.05±0.60	0.000
Diabetes	11 (26.8%)	40 (78.4%)	0.001
Hypertension	11 (26.8%)	35 (76%)	0.009
Dyslipidemia	12 (29.2%)	45 (78.9%)	<0.001
Metabolic Syndrome	12 (29.2%)	56 (82.4%)	<0.001